NCT01536899

Brief Summary

The investigators are interested in understanding personal factors such as medical conditions and mental health, as well as social and economic factors, that influence marijuana (and other substance) use in HIV-positive patients. Several alternative hypotheses will be evaluated in the proposed project:

  1. 1.healthier patients may self-select marijuana use;
  2. 2.marijuana use may be associated with consequences that create barriers to seeking healthcare;
  3. 3.marijuana use may have medicinal value that reduces the need for such care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
119

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2012

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

February 16, 2012

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 22, 2012

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
Last Updated

April 5, 2018

Status Verified

April 1, 2018

Enrollment Period

5.3 years

First QC Date

February 16, 2012

Last Update Submit

April 3, 2018

Conditions

HIV PositiveMarijuana Smoking

Keywords

HIV positiveMedical Marijuana

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

HIV positive and marijuana using volunteers

You may qualify if:

  • Participants will be patients in the HIV clinic.
  • Participants will have HIV.
  • Participants will sign a single consent form.
  • Participants will be marijuana users.

You may not qualify if:

  • Participants who test negative for marijuana will be excluded.
  • Volunteers who exhibit signs of drug intoxication or cognitive/mental impairment during the consent process will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wayne State University (HIV clinic, Tolan Park Medical Buiding)

Detroit, Michigan, 48201, United States

Location

Related Publications (1)

  • Woodcock EA, Greenwald MK, Chen I, Feng D, Cohn JA, Lundahl LH. HIV chronicity as a predictor of hippocampal memory deficits in daily cannabis users living with HIV. Drug Alcohol Depend Rep. 2023 Sep 13;9:100189. doi: 10.1016/j.dadr.2023.100189. eCollection 2023 Dec.

    PMID: 37736522DERIVED

MeSH Terms

Conditions

HIV SeropositivityMarijuana Smoking

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesMarijuana UseBehaviorSmoking, Non-Tobacco ProductsSmoking

Study Officials

  • Mark Greenwald, PhD

    Wayne State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 16, 2012

First Posted

February 22, 2012

Study Start

February 1, 2012

Primary Completion

June 1, 2017

Study Completion

June 1, 2017

Last Updated

April 5, 2018

Record last verified: 2018-04

Locations

US(1)